Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.21 USD
Change Today 0.00 / 0.00%
Volume 513.0
CAPS On Other Exchanges
As of 9:30 AM 07/30/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

John M. Holliman III

Executive Chairman and Chief Executive Officer, Capstone Therapeutics Corp.
AgeTotal Calculated CompensationThis person is connected to 26 board members in 5 different organizations across 7 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. John M. Holliman, III, also known as Jock, serves as a General Partner at Valley Ventures. Mr. Holliman founded Valley Ventures in early 1993. He has been the Executive Chairman and Chief Executive Officer of Capstone Therapeutics Corp. since April 5, 2006. Mr. Holliman served as the Managing Director of Valley National Bank of Arizona's venture capital program, where he oversaw 22 direct and three indirect investments in creating a successful portfolio from a $22 ...

Read Full Background

Corporate Headquarters*

1275 West Washington Street
Tempe, Arizona 85281

United States

Phone: 602-286-5520
Fax: --

Board Members Memberships*

Executive Chairman and Chief Executive Officer


Unknown/Other Education
Southern Methodist University
Southern Methodist University
Southern Methodist University
Master's Degree
Thunderbird School of Global Management

Other Affiliations*

Annual Compensation*

Total Annual Compensation$100,000

Stock Options*

Exercisable Options816,167
Exercisable Options Value$10,070
Unexercisable Options1,833
Total Value of Options$10,070
Total Number of Options818,000

Total Compensation*

Total Annual Cash Compensation$131,000
Total Short Term Compensation$100,000
Total Calculated Compensation$138,000
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CAPS:US $0.21 USD 0.00


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CAPSTONE THERAPEUTICS CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at